Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients

Transplant Proc. 1998 Aug;30(5):1857. doi: 10.1016/s0041-1345(98)00458-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Costs and Cost Analysis
  • Creatinine / blood
  • Cyclosporine / administration & dosage*
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • France
  • Humans
  • Immunosuppression Therapy / economics
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use
  • Infusions, Intravenous
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Male
  • Middle Aged
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine